India's Risdiplam launch dramatically cuts Spinal Muscular Atrophy (SMA) medicine cost to ₹15K. Learn how this affordable treatment offers new hope for patients.
https://www.mrmed.in/health-library/neurology/risdiplam-india-launch

#Risdiplam #SMA #IndiaHealth #AffordableMedicine #RareDisease #SpinalMuscularAtrophy #HealthNews #NatcoPharma #IndianPharma

📊 Long-Term Investment Advice (6th Aug 2024)

💡 Buy Natco Pharma
NSE: NATCOPHARM
Best Buy Range: 1210 - 1220
Sell Target: 1950 - 1960
Potential Return: 60 - 62%

🟢 Subscribe to our Ultra Investment Advice from the official website. Link in the comment!

#nifty50 #investmentadvice #longterminvestment #pharma #natcopharma